Add-on Valproate in Late Life Schizophrenia

Trial Profile

Add-on Valproate in Late Life Schizophrenia

Phase of Trial: Phase IV

Latest Information Update: 23 Sep 2016

At a glance

  • Drugs Valproate semisodium (Primary)
  • Indications Schizophrenia
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Jan 2009 Actual end date changed from Oct 2006 to Nov 2006 as reported by
    • 23 Jan 2009 Additional lead trial centres identified as reported by, last updated 23-Jan-2009.
    • 03 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top